What is the projected value of the artificial organs and bionics market by 2030?

The market is expected to reach USD 45.29 billion in 2030 on a 7.20% CAGR trajectory. Read More

Which segment currently dominates the artificial organs and bionics market?

Artificial organs lead with 70.26% device-type share, driven by critical demand in cardiac and renal support. Read More

Why is Asia-Pacific the fastest-growing regional market?

Breakthroughs such as Japan’s universal artificial blood and China’s brain-spine interfaces, combined with rising healthcare investment, propel a 10.62% CAGR through 2030. Read More

How are implantable systems gaining traction over wearable devices?

Advances in biocompatible materials, wireless charging, and miniaturised electronics enable fully internalised solutions that are growing at 9.35% CAGR. Read More

What are the main challenges limiting broader adoption?

High procedure costs, biocompatibility hurdles, and supply-chain dependence on rare-earth sensors continue to temper growth despite strong technology momentum. Read More

Which recent regulatory milestone could reshape the competitive landscape?

The FDA’s approval of first-in-human trials for gene-edited pig organs signals a potential long-range solution to organ scarcity and a new competitive frontier. Read More

Artificial Organs And Bionics Companies

This report lists the top Artificial Organs And Bionics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Artificial Organs And Bionics industry.